Results 41 to 50 of about 321,909 (338)

Atopic dermatitis [PDF]

open access: yesSouth African Medical Journal, 2014
The articles in this issue of CME reflect the views of a number of individuals who developed the guideline for the management of atopic dermatitis (AD) to improve the outcome of its treatment in South Africa (SA). AD has a major impact on the quality of life of sufferers and it is hoped that the articles and the guidelines they embody, if implemented ...
Sinclair, Werner, Green, Robin J.
openaire   +7 more sources

気管支喘息患者における細胞性免疫,ガンジダ抗原に対する遅延型反応の抑制 [PDF]

open access: yes, 1992
Delayed cutaneous hypersensitivity towards Candida albicans was examined in 200 patients with bronchial asthma in relation to patient age and the level of total IgE. 1.
Harada, Hideo   +7 more
core   +1 more source

Exosomes from Human Adipose Tissue-Derived Mesenchymal Stem Cells Promote Epidermal Barrier Repair by Inducing de Novo Synthesis of Ceramides in Atopic Dermatitis. [PDF]

open access: yes, 2020
Atopic dermatitis (AD) is a multifactorial, heterogeneous disease associated with epidermal barrier disruption and intense systemic inflammation. Previously, we showed that exosomes derived from human adipose tissue-derived mesenchymal stem cells (ASC ...
Cho, Byong Seung   +19 more
core   +1 more source

Systemic Immunomodulatory Treatments for Atopic Dermatitis

open access: yesJAMA dermatology
Key Points Question What is the relative efficacy and harm of lebrikizumab, the most recently approved biologic medication for atopic dermatitis compared with other systemic treatments?
Aaron M Drucker   +13 more
semanticscholar   +1 more source

Efficacy and Safety of Abrocitinib in Patients With Moderate-to-Severe Atopic Dermatitis

open access: yesJAMA dermatology, 2020
This randomized clinical trial investigates the efficacy and safety of abrocitinib in adolescents and adults with moderate-to-severe atopic dermatitis.
J. Silverberg   +10 more
semanticscholar   +1 more source

Staphylococcus Infection: Relapsing Atopic Dermatitis and Microbial Restoration

open access: yesAntibiotics, 2023
Atopic Dermatitis (AD) skin is susceptible to Staphylococcus aureus (SA) infection, potentially exposing it to a plethora of toxins and virulent determinants, including Panton-Valentine leukocidin (PVL) (α-hemolysin (Hla) and phenol-soluble modulins ...
John Hulme
doaj   +1 more source

Unraveling the skin; a comprehensive review of atopic dermatitis, current understanding, and approaches

open access: yesFrontiers in Immunology
Atopic dermatitis, also known as atopic eczema, is a chronic inflammatory skin disease characterized by red pruritic skin lesions, xerosis, ichthyosis, and skin pain.
Moeina Afshari   +4 more
semanticscholar   +1 more source

Atopic dermatitis endotypes and implications for targeted therapeutics.

open access: yesJournal of Allergy and Clinical Immunology, 2019
Recent research advancements indicate that atopic dermatitis (AD) is a complex disease characterized by different subtypes/phenotypes based on age, disease chronicity, ethnicity, filaggrin and IgE status, and underlying molecular mechanisms/endotypes ...
T. Czarnowicki   +3 more
semanticscholar   +1 more source

Malassezia pachydermatis Carriage in Dog Owners

open access: yesEmerging Infectious Diseases, 2005
Yeasts of the genus Malassezia serve as both commensal microorganisms and pathogens on the skin of humans and domestic animals. Although rare, cases of life-threatening fungemia in people have been attributed to Malassezia pachydermatis, for which dogs ...
Daniel O. Morris   +3 more
doaj   +1 more source

Emerging Methods to Objectively Assess Pruritus in Atopic Dermatitis. [PDF]

open access: yes, 2019
INTRODUCTION:Atopic dermatitis (AD) is an inflammatory skin disease with a chronic, relapsing course. Clinical features of AD vary by age, duration, and severity but can include papules, vesicles, erythema, exudate, xerosis, scaling, and lichenification.
Bhutani, Tina   +7 more
core   +1 more source

Home - About - Disclaimer - Privacy